Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.45 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.44 |
| ▸ | CPT2 | P23786 | 1/20 | 0.44 |
| ▸ | CPT1A | P50416 | 1/20 | 0.44 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221642 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL3970543 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL67008 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL19281111 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL8660979 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL3657071 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL5196744 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL90356 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL319255 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 | |
| SCHEMBL74160 | 1.00 | FAAH (0.59) | FAAHMEN1KMT2AMAPK1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1390 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| CN-121203552-B | Corrosion-resistant through silicon via copper film chemical mechanical polishing solution and application thereof | Xinyue Microelectronic Materials (Jiaxing) Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260108440-A1 | Personal Care Compositions | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-23 | — | — | US | claimed |
| US-20260107944-A1 | HIGH HYALURONATE MULTI-PURPOSE DISINFECTION SOLUTIONS FOR OPHTHALMIC APPLICATIONS | CIS BIOPHARMA AG (CH) | 2026-04-23 | — | — | US | claimed |
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | claimed |
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | L'OREAL (FR) | 2026-03-05 | — | — | US | claimed |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | L'OREAL (FR) | 2026-02-19 | — | — | US | claimed |
| US-12527814-B2 | Treatment of an ocular infection, composition and methods thereof | THE UNIVERSITY OF HONG KONG (CN) | 2026-01-20 | — | — | US | claimed |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CIS BIOPHARMA AG (CH) | 2026-01-20 | — | — | US | claimed |
| EP-4633589-A1 | HAIR TREATMENT COMPOSITIONS THAT IMPART SHINE AND LUSTER | L'OREAL (FR) | 2025-10-22 | — | — | EP | claimed |
| WO-1999034768-A2 | HAIR CONDITIONING COMPOSITION | UNILEVER PLC (GB) | 1999-07-15 | — | — | WO | claimed |
| EP-0562639-B1 | Shampoo compositions and suspending agent therefor | CURTIS HELENE IND INC (US) | 1997-10-29 | — | — | EP | claimed |
| US-5665267-A | Shampoo compositions and suspending agent therefor | HELENE CURTIS, INC. (US) | 1997-09-09 | — | — | US | claimed |
| EP-0562637-B1 | Opacifier for water-based compositions | CURTIS HELENE IND INC (US) | 1997-05-28 | — | — | EP | claimed |
| US-5587154-A | COMPRISING A FATTY-TERT, SECONDARY- OR PRIMARY-AMINE AND AN ACID AS DISPERSANTS | HELENE CURTIS, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-5393519-A | Homogeneous; containing a conditioner | HELENE CURTIS, INC. (US) | 1995-02-28 | — | — | US | claimed |
| EP-0437006-B1 | Composition that protects dyed hair from fading | COLGATE PALMOLIVE CO (US) | 1994-12-07 | — | — | EP | claimed |
| EP-0562639-A1 | Shampoo compositions and suspending agent therefor | HELENE CURTIS, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| EP-0562637-A1 | Opacifier for water-based compositions | HELENE CURTIS, INC. (US) | 1993-09-29 | — | — | EP | claimed |
| EP-0109074-A1 | Quarternary ammonium derivatives of amino acid units | INOLEX CHEMICAL COMPANY (US) | 1984-05-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060909-A1 | HAIR CARE COMPOSITION COMPRISING TERTIARY AMIDOAMINES SURFACTANT (TAS), SALICYLIC ACID, FREE OF FATTY ALCOHOL AND PH= 6.5 | KRT18, ADH1A, ADH1C | FAAH 9/4885MEN1 3620/4885KMT2A 2104/4885 |
| US-20260107944-A1 | HIGH HYALURONATE MULTI-PURPOSE DISINFECTION SOLUTIONS FOR OPHTHALMIC APPLICATIONS | PKD2, CD44, HCN4 | FAAH 1602/4885MEN1 1427/4885KMT2A 708/4885 |
| US-12527327-B2 | High hyaluronate multi-purpose disinfection solutions for ophthalmic applications | CD44, HCN4, MUC1 | FAAH 1191/4885MEN1 458/4885KMT2A 955/4885 |
| US-20260144726-A1 | POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER | HAO2, HADH, LDHA | FAAH 364/4885MEN1 2466/4885KMT2A 2037/4885 |
| US-20260047988-A1 | HAIR COSMETIC COMPOSITIONS AND METHOD OF TREATING HAIR | HCAR1, CUTA, HCAR3 | FAAH 276/4885MEN1 4338/4885KMT2A 3164/4885 |
| US-20260108440-A1 | Personal Care Compositions | PBDC1, PIEZO1, TRPC7 | FAAH 2667/4885MEN1 3357/4885KMT2A 2504/4885 |
| US-12527814-B2 | Treatment of an ocular infection, composition and methods thereof | Q6ZSR9, TMT1A, TBK1 | FAAH 3651/4885MEN1 3457/4885KMT2A 693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.